🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even

EntrackrEntrackr · 2m ago
Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even
Medial

Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even Mosaic Wellness, the parent company of digital-first health and wellness brands Man Matters and Bodywise, continued its growth trajectory in FY25, more than doubling its scale while significantly narrowing its losses in the fiscal year ending March 2025. The company’s operating revenue spiked 2.2X to Rs 736 crore in FY25 from Rs 333 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Mosaic Wellness is a digital-first consumer health platform that runs separate brands for men, women, and kids. Its flagship brand ManMatters offers solutions across derma, sexual health, hygiene, and nutrition. The company has not disclosed the revenue from its brands separately but the sale of health and wellness products was the only source of income for Mosaic Wellness in FY25. It also added Rs 13 crore from the interest on deposits and gain on sale on investments which brought its total revenue to Rs 749 crore in the last fiscal year. The company’s advertising expense remained its largest cost centre, accounting for 35% of the total spend. This cost nearly doubled to Rs 267 crore in FY25 from Rs 138 crore. The cost of materials also grew sharply to Rs 193 crore, forming over 25% of the expenditure. Meanwhile, the company’s employee benefit expense remained stable at Rs 63 crore in FY25. Overall, Mosaic Wellness’ total expense doubled to Rs 758 crore in FY25 from Rs 380 crore in FY24. With the company’s revenue outpacing expense growth, the company managed to bring down its net loss by 69%, narrowing it to Rs 12 crore in FY25 from Rs 39 crore in FY24. Its ROCE and EBITDA margin stood at -6.55% and -2.79%, respectively. Mosaic Wellness spent Rs 1.03 to earn a rupee of operating revenue in FY25, an improvement from Rs 1.14 in the previous year. The firm closed the fiscal with Rs 49 crore in cash and bank balances, while its current assets nearly doubled to Rs 325 crore. According to TheKredible, the company has raised a total of $63 million of funding till date, having Elevation Capital, Peak XV Partners and Matrix Partners as its lead investors. The company’s co-founders Revant Bhate and Dhyanesh Shah own around 35% of the company.

1

Related News

Man Matters-parent Mosaic Wellness clocks Rs 333 Cr revenue in FY24

EntrackrEntrackr · 11m ago
Man Matters-parent Mosaic Wellness clocks Rs 333 Cr revenue in FY24
Medial

Mosaic Wellness, the parent firm of Man Matters, Boywise, and Little Joys, recorded over 61% year-on-year growth in its operating scale and crossed the Rs 300 crore revenue threshold in the last fiscal year. The firm also narrowed losses by 37% in FY24. Mosaic Wellness’ revenue from operations surged to Rs 333 crore in FY24 from Rs 206 crore in FY23, according to its consolidated annual financial statements sourced from the Registrar of Companies. Founded in 2020 by Revant Bhate and Dhyanesh Shah, Mosaic Wellness is a digital-first consumer health platform that runs three separate brands for men, women, and kids. Its flagship brand ManMatters offers solutions across derma, sexual health, hygiene, and nutrition. The sale of health and wellness products was the only source of income for Mosaic Wellness in FY24. It also added Rs 8 crore from the interest on deposits and gain on sale on investments, bringing its total revenue to Rs 342 crore in FY24. Mosaic Wellness's advertising cost increased to Rs 138 crore in FY24, marking a 38% year-on-year increase. Its procurement costs grew 52% to Rs 93 crore, while employee benefits rose by 33% to Rs 52 crore. Other expenses, including commissions, packaging, legal, and overheads, increased, bringing total expenses to Rs 380 crore in FY24. Despite expenses, Mosaic Wellness managed to reduce its losses by 37% to Rs 39 crore in FY24, compared to Rs 62 crore in FY23. Its ROCE and EBITDA margin improved to -24.2% and -10.8%, respectively. The company reported total current assets of Rs 188 crore, including Rs 61 crore in cash and bank balances by the end of FY24. Mosaic Wellness has raised over $35 million to date, including $24 million in a Series A round led by Peak XV, along with existing investors Elevation Capital and Matrix Partners India. The company is reportedly in talks to raise a new round. In a market revitalized by HUL’s acquisition of Minimalist, attention has turned to firms like Mosaic Wellness that have scaled past Rs 300 crore in revenue. The company should feel confident having crossed this threshold and having the runway to explore further funding or other strategic avenues.

Man Matters-parent Mosaic Wellness crosses Rs 200 Cr revenue in FY23

EntrackrEntrackr · 1y ago
Man Matters-parent Mosaic Wellness crosses Rs 200 Cr revenue in FY23
Medial

Digital health and wellness consultation startup Mosaic Wellness grew at a rapid clip during the last two fiscal years, raising its scale over 18X from Rs 11.47 crore in FY21 to surpass the Rs 200 crore revenue mark in FY23. At the same time, the firm posted Rs 62 crore in losses in FY23. Mosaic Wellness’s revenue from operations surged 163% to Rs 207 crore in FY23 from Rs 78 crore in FY22, its annual financial statements filed with the Registrar of Companies show. Founded in 2020 by Revant Bhate and Dhyanesh Shah, Mosaic Wellness is a digital-first consumer health platform that runs three separate brands for men, women, and kids. Its flagship brand ManMatters offers solutions across derma, sexual health, hygiene, and nutrition. Income from the sale of health and wellness products is the primary source of revenue for Mosaic Wellness. The company also made Rs 8 crore from interest, tallying its total revenue to Rs 215 crore in FY23. Mosaic Wellness spent a whopping Rs 100 crore on advertising and promotions which is 36% of its overall expenditure. Its cost of procurement of health and wellness products surged 2.6X to Rs 60 crore in FY23. Its employee benefits, freight, commissions, legal/ professional, and other overheads took the overall cost up by 2.2X to Rs 277 crore in FY23 from Rs 126 crore in FY22. Head to TheKredible for the detailed expense breakup. Expense Breakdown Total ₹ 126 Cr https://thekredible.com/company/mosaic-wellness/financials View Full Data To access complete data, visithttps://thekredible.com/company/mosaic-wellness/financials Total ₹ 277 Cr https://thekredible.com/company/mosaic-wellness/financials View Full Data To access complete data, visithttps://thekredible.com/company/mosaic-wellness/financials Employee benefit expense Employee benefit expense Cost of materials consumed Cost of materials consumed Advertising promotional expenses Advertising promotional expenses Transportation Cost Transportation Cost Commission expense Commission expense Legal professional charges Legal professional charges Others To check complete Expense Breakdown visit thekredible.com View full data With a two-fold surge in advertising and employee benefits, losses for the Mumbai-based firm increased 49.4% to Rs 62 crore in FY23 from Rs 42 crore in FY22. Its ROCE and EBITDA margin stood at -38% and -21% respectively. On a unit level, it spent Rs 1.34 to earn a rupee in FY23. Mosaic Wellness has raised over $34 million across rounds including its $24 million Series A led by Peak XV along with the participation of Elevation Capital and Matrix Partners in November 2021. According to the startup data intelligence platform TheKredible, the company was valued at $240 million in its last fundraise. Elevation emerged as the latest external shareholder with a 24.1% stake followed by PeakXV and Matrix Partners with 17.9% and 16.3%, respectively. FY22-FY23 FY22 FY23 EBITDA Margin -46% -21% Expense/₹ of Op Revenue ₹1.61 ₹1.34 ROCE -23% -38% The emergence of startups like Mosaic Wellness can usually be considered a net positive as they take away share from shady operators offering unqualified advice for health related issues. However, with their own dependence on pushing wellness products, many with potentially dubious claims when it comes to benefits, the firm does run the risk of slipping up on credibility at some stage. The high dependence on advertising and promotions is a clear indicator of the efforts required to wean away clientele from smaller mostly unlicensed players. By now, the firm should be in a position to assume leadership, or clear focus on a specific area where it can, and has made a discernible difference to its customers, and build on that for the future.

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven

EntrackrEntrackr · 1m ago
Healthians posts Rs 263 Cr revenue in FY25; nears breakeven
Medial

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven Healthians didn't manage notable growth in the fiscal year ending March 2025. However, the WestBridge-backed company narrowed its losses by 89% year on year and neared break-even during the same period. The firm’s operating revenue increased 8% year-on-year to Rs 263 crore in FY25, up from Rs 243 crore in FY24, as per its consolidated financial statements filed with the Registrar of Companies (RoC). Including non-operating income of Rs 7 crore, the company’s total income grew 7% to Rs 270 crore during the year. Cost optimisation played a key role in supporting the company’s financial recovery. Total expenses declined 8% to Rs 275 crore in FY25, compared to Rs 298 crore last year. Among the major cost heads, employee benefits, the largest expense category, dropped 13% year-on-year to Rs 104 crore in FY25 from Rs 120 crore in FY24. Cost of materials contracted 7% to Rs 54 crore. Advertising costs rose 10% to Rs 43 crore. Meanwhile, depreciation and finance costs remained stable at Rs 29 crore and Rs 15 crore, respectively. The improvement in revenue and control of key expenses helped Healthians bring down its losses sharply by 89% to Rs 5 crore in FY25 from Rs 45 crore in FY24. The firm posted positive EBITDA of Rs 32 crore in FY25 with EBITDA margin of 12.17%. Its ROCE stood at 2.73% in the same period. On a unit basis, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25. The firm’s current assets increased slightly to Rs 170 crore including cash and bank balances worth Rs 49 crore in the fiscal. According to startup data intelligence platform TheKredible, Healthians has raised a total of $75 million of funding till date, having WestBridge, BEENEXT, DG Ventures and Youwecan as its lead investors. The company’s founder and CEO, Deepak Sahni owns 6.5% of the company.

Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr

EntrackrEntrackr · 4m ago
Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr
Medial

Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr Gameskraft’s FY25 numbers reflect strong performance before the RMG ban. The firm reported double-digit revenue growth and maintained profitability during the fiscal year. The Indian government’s recent ban on real-money gaming formats has disrupted the sector overnight, but Gameskraft’s FY25 numbers reflect strong performance before the clampdown. The firm reported double-digit revenue growth and maintained profitability during the fiscal year. Gameskraft’s revenue from operations grew 12% to Rs 3,896 crore in FY25 from Rs 3,475 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Gameskraft operated popular gaming apps such as Rummy Culture, Playship, Pocket 52, RummyPrime, Ludo Culture, and Rummy Time. Its revenue (gross gaming revenue) came from platform fee or commission charged as a percentage of the buy-in fees users invest in games, which contributed Rs 3,882 crore (99.6% of operating revenue), registering a 12.2% growth. Its real estate business added Rs 11 crore, while other income sources contributed Rs 3 crore in FY25. The Bengaluru-based company made an additional Rs 113 crore from non-operating sources which pushed its total revenue to Rs 4,009 crore in FY25. On the cost side, promotional spending emerged as the single largest expense and accounted for 75% of total burn. To the tune of scale, this cost surged 58% to Rs 2,072 crore in FY25 from Rs 1,315 crore in FY24. Employee benefits, on the other hand, saw a decline of 11% to Rs 410 crore, while legal and professional fees fell 22.8% to Rs 112 crore in FY25. Overall, the company’s total expenses shot up 24% to Rs 2,766 crore in FY25 as against Rs 2,232 crore in FY24. See TheKredible for the detailed cost breakdown during the last fiscal year. Despite the jump in ad spend, Gameskraft managed to sustain profitability on the back of its strong topline and controlled costs in other areas. Its net profit stood at Rs 976 crore in FY25, slightly higher than the Rs 947 crore posted in FY24. It's worth noting that we have excluded exceptional items worth Rs 270.5 crore in the calculation of net profit of the company. Gameskraft's ROCE and EBITDA margin stood at 58.40% and 31.63%, respectively. On a unit basis, Gameskraft spent Rs 0.71 to earn a rupee of operating revenue in FY25. The company recorded current assets worth Rs 2,232 crore in FY25 which includes Rs 253 crore in cash and bank balances and Rs 1,319 crore invested in mutual funds. While Gameskraft’s FY25 numbers were unaffected, the Indian government’s new gaming law effective August 2025 has forced the company to halt its real-money operations, including shutting down “Add Cash” features and discontinuing its flagship rummy platform RummyCulture, alongside pausing its poker venture Pocket52 earlier in the year. The move, mandated by the Promotion and Regulation of Online Gaming Act, has also led Gameskraft to publicly state it will not pursue a legal challenge, instead opting for full compliance. Given that real-money gaming contributed nearly all of Gameskraft’s FY25 revenue, the ban is expected to significantly impact its business model, revenue streams, and growth trajectory going forward.

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples

EntrackrEntrackr · 2m ago
Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples
Medial

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples HealthKart, a nutrition and supplement e-commerce platform, recorded a 3X year-on-year jump in profit after turning profitable in FY24. The Gurugram-based company’s sharp profit growth was steered by strong sales momentum and a controlled cost structure. Healthkart’s operating revenue grew 29% to Rs 1,313 crore in FY25 from Rs 1,021 crore in FY24, according to its consolidated financial statement sourced from the Registrar of Companies (RoC). HealthKart owns and manufactures eight nutritional brands including popular supplement brands like MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza, and Gritzo. Sales of products formed 97% of total revenue which rose by 29% to Rs 1,277 crore in FY25. Collections from services also increased by 16% to Rs 36 crore. Notably, non-operating revenue increased to Rs 55 crore in the last fiscal year from Rs 48 crore in FY24. The cost of materials accounted for the largest share of the company’s expenditure at 49%. To the tune of scale, this cost rose 26% to Rs 623 crore in FY25 from Rs 495 crore in FY25. Advertising spend saw a sharper rise of 39% to Rs 263 crore, while commission expenses increased 22% to Rs 82 crore. In contrast, employee benefit costs declined 5% to Rs 115 crore. Overall, Healthkart managed to keep its cost growth below revenue expansion. Its total expenses rose 23% to Rs 1,273 crore in FY25 from Rs 1,032 crore in FY24. The company’s profit surged over 3X to Rs 120 crore in FY25, while its ROCE and EBITDA margin improved to 5.45% and 6.02%, respectively. On a unit basis, Healthkart spent Re 0.97 to earn a rupee of operating revenue in FY25, compared to Rs 1.01 in FY24. As of FY25, its current assets stood at Rs 971 crore including Rs 73 crore in cash and bank balances. According to startup data intelligence platform TheKredible, Healthkart has raised a total of $382 million of funding till date, having Peak XV Partners, Temasek and Sofina as its lead investors. The company’s founder and CEO, Sameer Maheshwari owns 12% of the company.

CarTrade posts Rs 193 Cr in revenue, profit doubles to Rs 64 Cr

EntrackrEntrackr · 2m ago
CarTrade posts Rs 193 Cr in revenue, profit doubles to Rs 64 Cr
Medial

CarTrade posts Rs 193 Cr in revenue, profit doubles to Rs 64 Cr Automobile classifieds platform CarTrade announced its financial results for the second quarter of FY26, reporting a 25% year-on-year increase in revenue and a two-fold rise in profit compared to Q2 FY25. CarTrade’s revenue from operations grew 25% to Rs 193.41 crore in Q2 FY26 in contrast to Rs 154.2 crore in Q2 FY25. The company also added another 28.73 crore in other income, taking its total income for Q2 FY26 to Rs 222.14 crore. The Mumbai-based company operates across three segments: Consumer, Remarketing, and Classifieds. Revenue from the Consumer segment accounted for 39.4% of total operating income, rising to Rs 76.24 crore in Q2 FY26 from Rs 55.62 crore in Q2 FY25. The Remarketing and Classifieds segments contributed Rs 62.62 crore and Rs 55.5 crore, respectively. On the expense front, employee benefits accounted for 55% of total spending, increasing 11% to Rs 77.5 crore during the period. CarTrade’s total expenses grew modestly by 5% to Rs 142.2 crore in Q2 FY26. A 25% year-on-year rise in operating revenue, coupled with controlled expenses, helped the firm double its profit to Rs 64 crore in Q2 FY26 from Rs 30.7 crore in Q2 FY25. On a half-yearly basis, the company’s revenue rose 24% year-on-year to Rs 366.45 crore, while its profit more than doubled to Rs 111.13 crore. The firm has also appointed Varun Sanghi as its Chief Strategy Officer (CSO) and senior management personnel.

Tata 1mg revenue nears Rs 2,400 Cr in FY25, trims losses

EntrackrEntrackr · 5m ago
Tata 1mg revenue nears Rs 2,400 Cr in FY25, trims losses
Medial

Tata 1mg, the digital healthcare platform backed by Tata Digital, continued its growth trajectory in the fiscal year ending March 2025 while straining its losses. Tata 1mg’s consolidated revenue rose 22% to Rs 2,392 crore in FY25 from Rs 1,968 crore in FY24, according to Tata Sons’ Annual Report for the fiscal year. Tata 1mg is a health tech startup for online orders of allopathic, ayurvedic, homeopathic medicines, vitamins, nutrition supplements, and other health products, delivered to the home. 1mg’s revenue was split across two entities: Tata 1mg Technologies, which clocked Rs 2,016.5 crore, and Tata 1mg Healthcare Solutions, which contributed Rs 375.5 crore in FY25. The company's total cost rose by 17% to Rs 2682 crore in FY25, up from Rs 2303 crore in FY24. The Gurugram-based company posted a consolidated loss of Rs 276 crore in FY25, 12% lower than the Rs 313 crore loss reported in FY24. On a unit basis, the company spent Rs 1.12 to earn a rupee of operating revenue in FY25. On the asset side, Tata 1mg reported total assets of Rs 2,025 crore at the end of FY25 while its total liabilities reached Rs 1,190 crore. In the e-health space, Tata 1mg competes with Reliance-backed Netmeds, PharmEasy, and Apollo 24/7. Tata Digital acquired a 55% stake in 1mg in June 2021 but has since gained around 8.5% additional stake in the e-medicine platform. According to TheKredible, Tata Digital currently holds a 63.5% stake in 1mg, which was last valued at 1.25 billion. Tata Digital reported a standalone revenue of Rs 546.9 crore and a loss of Rs 827.5 crore in FY25, indicating continued investment in its digital commerce bets including 1mg and other verticals such as BigBasket, Cult.fit, and the recently launched Tata Neu.

The Souled Store nears Rs 500 Cr revenue in FY25; profits decline 38%

EntrackrEntrackr · 19d ago
The Souled Store nears Rs 500 Cr revenue in FY25; profits decline 38%
Medial

The Souled Store nears Rs 500 Cr revenue in FY25; profits decline 38% After recording over 50% year on year growth in FY24, direct to consumer pop culture brand The Souled Store maintained its growth pace in FY25 and posted a 37% rise in operating revenue. However, profitability slipped marginally during the year as costs increased. The Souled Store’s revenue from operations grew to Rs 492 crore in FY25 from Rs 360 crore in FY24, according to its annual financial statements sourced from the Registrar of Companies RoC. Founded in 2014, The Souled Store designs, manufactures, and sells pop culture inspired apparel, drawing from themes across superheroes, movies, and television shows. Over the years, the company has expanded its product portfolio to include footwear, books, mobile covers, notebooks, mugs, and other lifestyle merchandise, sold through both online and offline channels. Income from the sale of products across physical stores and online platforms accounted for 98.5% of the company’s operating revenue and rose 36.8% to Rs 485 crore in FY25. The remaining operating income was derived from membership fees. On the cost side, procurement remained the largest expense for the brand and accounted for a significant portion of total expenditure. With the company scaling its operations, procurement costs increased 40.8% year on year to Rs 210 crore in FY25. Employee benefit expenses and marketing spends stood at Rs 54 crore and Rs 57 crore respectively during the year. Marketplace commissions, rent, transportation, and other overheads further pushed total expenditure up by 36% to Rs 487 crore in FY25 compared to Rs 358 crore in FY24. Despite posting healthy top line growth, rising costs particularly higher employee benefits and marketing spends impacted profitability. As a result, profit declined by 37.6% to Rs 11 crore in FY25 from Rs 17.67 crore in FY24. From a margin perspective, The Souled Store reported positive ROCE and EBITDA margins of 7% and 9.7% respectively. On a unit economics basis, the company spent Rs 0.99 to earn every rupee of operating revenue during FY25. The Souled Store has raised nearly $30 million in funding to date. This includes a $16 million round led by Xponentia Capital in 2023 and a $10 million round led by Elevation Capital in 2021. According to startup data intelligence platform TheKredible, Elevation Capital remains the company’s largest external stakeholder followed by Xponentia Capital. Within the wider competitive set, The Souled Store faces competition from brands like Rare Rabbit, which posted Rs 636 crore in revenue with a Rs 76 crore profit in FY24 and has not yet filed for FY25. Bewakoof reported revenue of Rs 173 crore in FY25, while Virat Kohli-backed Wrogn recorded a 9% year on year decline in revenue to Rs 223 crore in FY25. The drop in friction in the manufacturing and distribution chain, an outcome of the efficiencies that have crept in over the past few years, means competition can come from pretty much anywhere now, from Instagram influencers to pop up stores that can deliver products at the same or even lower cost. This places a special premium on getting the ideas right, sourcing right, and building the buzz to sustain sales enough to pay for the duds. Innovations like collectibles will matter at some stage, as will the ability to strike and protect interesting licensing deals.

Pee Safe reports Rs 82 Cr revenue in FY25, nears breakeven

EntrackrEntrackr · 15d ago
Pee Safe reports Rs 82 Cr revenue in FY25, nears breakeven
Medial

Pee Safe improved its financial performance in FY25 as the company continued to scale while tightening its cost structure. The Gurugram-based firm reduced its losses by nearly 70% during the fiscal year ending March 2025. Pee Safe’s revenue from operations grew 46% to Rs 82 crore in FY25 from Rs 56 crore in FY24, as per its financial statements filed with the Registrar of Companies (RoC). Launched in 2013 by Vikas Bagaria and Srijana Bagaria, Pee Safe generates revenue primarily from sales of sanitary, personal hygiene, and intimate care products across online marketplaces, offline retail, and its direct-to-consumer channels. Revenue from these products was the sole source of revenue for the company. Cost of materials remained the largest cost component for the company, forming around 31% of total expenditure. This cost rose 29% to Rs 27 crore in FY25. Advertising and promotional spending, the second largest cost head, increased 16% to Rs 26 crore. Employee benefit expenses went up 18% to Rs 13 crore, while commission and freight costs stood at Rs 5 crore each. Overall, Pee Safe’s total expense increased 24% to Rs 86.5 crore in FY25 from Rs 70 crore in FY24. With the company’s revenue growth outpacing expense growth, Pee Safe managed to curb its losses by 69% to Rs 4 crore in FY25 from Rs 13 crore in FY24. Its ROCE and EBITDA margin stood at -46.25% and -4.15% respectively. On a unit level, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25, improving from Rs 1.25 in FY24. Pee Safe’s current assets stood at Rs 24 crore, while cash and bank balances were reported at Rs 2 crore during FY25. According to TheKredible, Pee Safe has raised $13.55 million in funding to date, with Alkemi Partners as its lead investor. Its founder & CEO, Vikas Bagaria, owns 11.20% of the company. Either way, the firm is not just close to breakeven, but close to key milestones like the Rs 100 crore mark, profitability and possibly much more, if it can stay focused and deliver on its core promise.

Download the medial app to read full posts, comements and news.